The estimated Net Worth of Matthew C Wallis is at least $2.66 Milhão dollars as of 7 April 2021. Dr Wallis owns over 400,000 units of IMAC Inc stock worth over $1,769,211 and over the last 6 years he sold IMAC stock worth over $640,000. In addition, he makes $254,177 as COO & Director at IMAC Inc.
Sign up
Dr Wallis IMAC stock SEC Form 4 insiders trading
Dr has made over 1 trades of the IMAC Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 400,000 units of IMAC stock worth $640,000 on 7 April 2021.
The largest trade he's ever made was selling 400,000 units of IMAC Inc stock on 7 April 2021 worth over $640,000. On average, Dr trades about 200,000 units every 0 days since 2019. As of 7 April 2021 he still owns at least 1,751,694 units of IMAC Inc stock.
You can see the complete history of Dr Wallis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Matthew C. Wallis biography
Dr. Matthew C. Wallis is the COO & Director at IMAC Inc.
What is the salary of Dr Wallis?
As the COO & Director of IMAC Inc, the total compensation of Dr Wallis at IMAC Inc is $254,177. There are no executives at IMAC Inc getting paid more.
How old is Dr Wallis?
Dr Wallis is 47, he's been the COO & Director of IMAC Inc since . There are 1 older and 1 younger executives at IMAC Inc. The oldest executive at IMAC Holdings Inc is Sheri Gardzina CPA, CPA, 52, who is the CFO & Corp. Sec..
What's Dr Wallis's mailing address?
Matthew's mailing address filed with the SEC is C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD, TN, 37027.
Insiders trading at IMAC Inc
Over the last 6 years, insiders at IMAC Inc have traded over $640,000 worth of IMAC Inc stock and bought 19,852 units worth $9,124 . The most active insiders traders include Cary Sucoff, Matthew C Wallis, eGerard M Jr Hayden. On average, IMAC Inc executives and independent directors trade stock every 48 days with the average trade being worth of $25,399. The most recent stock trade was executed by Cary Sucoff on 20 December 2023, trading 3,333 units of IMAC stock currently worth $3,366.
What does IMAC Inc do?
IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life-science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages more than 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes including Ozzie Smith, David Price, Mike Ditka and Tony Delk. IMAC’s outpatient medical clinics emphasize treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids.
What does IMAC Inc's logo look like?
Complete history of Dr Wallis stock trades at IMAC Inc
IMAC Inc executives and stock owners
IMAC Inc executives and other stock owners filed with the SEC include:
-
Dr. Matthew C. Wallis,
COO & Director -
Jeffrey S. Ervin M.B.A.,
Chairman & CEO -
Sheri Gardzina CPA, CPA,
CFO & Corp. Sec. -
Sandy Miller,
Chief of Staff -
Norleidy Hernandez,
HR Director -
Frank DeVito III,
Director of Sales -
Jeff Ervin,
Chief Exec. Officer -
Benjamin S Lerner,
Chief Operating Officer -
Jeffrey S Ervin,
Chief Executive Officer -
Sheri Gardzina,
Chief Financial Officer -
Maurice E. Evans,
Director -
Cary Sucoff,
Director -
Michael D Pruitt,
Director -
Gerard M Jr Hayden,
Director -
Dean Weiland,
Director -
David Ellwanger,
Director -
George P Hampton,
Director -
Matthew C Wallis,
Chief Operating Officer